Open AccessA case report on hydroxychloroquine induced maculopapular rashes: The immunosuppressant and corticosteroid therapy
Author(s) -
Sunil Kumar Salkapuram,
Elumalai Karthikeyan,
Eluri Kalpana,
Elumalai Manogaran,
Mallu Keerthana,
Srinivasan Sivaneswari,
Ranjan Chanda,
Sivannan Srinivasan
Publication year - 2020
Publication title -
precision medical sciences
Language(s) - English
Resource type - Journals
ISSN - 2642-2514
DOI - 10.1002/prm2.12024
Subject(s) - hydroxychloroquine , medicine , dermatology , maculopapular rash , forehead , scalp , surgery , covid-19 , disease , infectious disease (medical specialty) , rash
Maculopapular rashes could even be an assortment of hasty characterized by grade, ruddy region on the skin that is secured with little intersecting bumps. During this case, a 55‐year‐old woman patient has developed maculopapular rashes over the body. It is a medical reaction caused because of the hydroxychloroquine, which the patient has taken for her joint pains. Simultaneous development of blisters over the forehead, scalp, upper and lower limbs, which eventually get ruptured and formed various erosions. This episode was once severe because of the repeated intake of hydroxychloroquine as a daily regimen. This hydroxychloroquine resulted in pustules that were investigated and excision biopsy of the ruptured erosion was once administered and verified as maculopapular rashes. The patient was treated with immunosuppression, systemic, and topical corticosteroids for a month for the management and treatment of the rashes.